Han, S.-O., Amson, B., Busch, K., Ronzitti, G., Li, S., Mingozzi, F., & Koeberl, D. D. (2016). 49. Minimum Effective Dose of Liver-Targeted Gene Therapy for Pompe Disease Reduced 10-Fold from Prior Estimates. In Molecular Therapy (Vol. 24, pp. S22–S22). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)32858-1

Han, Sang-oh, Benjamin Amson, Korie Busch, Giuseppe Ronzitti, Songtao Li, Federico Mingozzi, and Dwight D. Koeberl. “49. Minimum Effective Dose of Liver-Targeted Gene Therapy for Pompe Disease Reduced 10-Fold from Prior Estimates.” In Molecular Therapy, 24:S22–S22. Elsevier BV, 2016. https://doi.org/10.1016/s1525-0016(16)32858-1.

Han S-O, Amson B, Busch K, Ronzitti G, Li S, Mingozzi F, et al. 49. Minimum Effective Dose of Liver-Targeted Gene Therapy for Pompe Disease Reduced 10-Fold from Prior Estimates. In: Molecular Therapy. Elsevier BV; 2016. p. S22–S22.

Han, Sang-oh, et al. “49. Minimum Effective Dose of Liver-Targeted Gene Therapy for Pompe Disease Reduced 10-Fold from Prior Estimates.” Molecular Therapy, vol. 24, Elsevier BV, 2016, pp. S22–S22. Crossref, doi:10.1016/s1525-0016(16)32858-1.

Han S-O, Amson B, Busch K, Ronzitti G, Li S, Mingozzi F, Koeberl DD. 49. Minimum Effective Dose of Liver-Targeted Gene Therapy for Pompe Disease Reduced 10-Fold from Prior Estimates. Molecular Therapy. Elsevier BV; 2016. p. S22–S22.